ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,745.77
      0.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Savient Pharmaceuticals (MM) (SVNTE)

      7. Savient Pharmaceuticals (MM) (SVNTE) News

      SVNTE

      Savient (SVNTE)

      Savient Pharmaceuticals (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SVNTE
      DateTimeSourceHeadlineSymbolCompany
      01/26/20064:23PMBusiness WireSavient Pharmaceuticals Files Form 10-Q For Period Ended September 30, 2005; Meets Final Filing Deadline for All Late Reports ReNASDAQ:SVNTESavient Pharmaceuticals (MM)
      01/23/20063:45PMBusiness WireSavient Pharmaceuticals Receives Additional Extension from NASDAQNASDAQ:SVNTESavient Pharmaceuticals (MM)
      01/19/20065:19PMBusiness WireSavient Completes Restatement of 2004 and Prior Period Results; Amended and Initial Quarterly Reports for 2005 Expected to be FiNASDAQ:SVNTESavient Pharmaceuticals (MM)
      01/09/20066:30PMBusiness WireSavient Pharmaceuticals Closes Sale of Delatestryl(R) Product to Indevus PharmaceuticalsNASDAQ:SVNTESavient Pharmaceuticals (MM)
      01/03/20066:30PMBusiness WireSavient Pharmaceuticals Receives Two-Week Extension from NASDAQ Regarding Late FilingsNASDAQ:SVNTESavient Pharmaceuticals (MM)
      12/02/20052:30AMPR Newswire (US)Barr, Organon and Savient Finalize Mircette(R) Settlement and AcquisitionNASDAQ:SVNTESavient Pharmaceuticals (MM)
      11/18/20055:15PMBusiness WireSavient Receives Expected Nasdaq Notice Regarding Delay in Filing Third Quarter Form 10-QNASDAQ:SVNTESavient Pharmaceuticals (MM)
      11/14/20058:01AMPR Newswire (US)Savient's Puricase(R) (PEG-uricase) Substantially Reduces and Sustains Lower Plasma Urate Levels in Patients with Treatment-ResiNASDAQ:SVNTESavient Pharmaceuticals (MM)
      11/07/20057:41AMBusiness WireSavient Pharmaceuticals Provides Business Update; Financial Overview and Recent Strategic DevelopmentsNASDAQ:SVNTESavient Pharmaceuticals (MM)
      11/02/20056:30AMBusiness WireSavient Pharmaceuticals to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceNASDAQ:SVNTESavient Pharmaceuticals (MM)
      11/01/20056:30PMBusiness WireSavient Pharmaceuticals to Provide Business Update on November 7, 2005NASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/31/20054:41PMBusiness WireCORRECTING and REPLACING Savient Pharmaceuticals Receives FDA Approval to Market Soltamox(TM); The First Oral Liquid Tamoxifen iNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/31/20052:00PMBusiness WireSavient Pharmaceuticals Receives FDA Approval to Market Soltamox(R); The First Oral Liquid Tamoxifen in U.S.; U.K.-based LiquidsNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/28/20053:18PMBusiness WireSavient Pharmaceuticals Receives Filing Extension from NasdaqNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/26/20055:59PMBusiness WireSavient Pharmaceuticals Determines Periods Affected for Restatement Include Six Months Ended June 30, 2005 and Fiscal Years EndeNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/21/20056:30PMBusiness WireSavient Pharmaceuticals, Inc. Announces Second Amended Complaint in Purported Class Action LawsuitNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/14/20057:00AMBusiness WireSavient Pharmaceuticals, Inc. to Present at the Upcoming BIO Investor Forum 2005NASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/14/20056:30AMBusiness WireSavient Audit Committee Completes ReviewNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/05/20056:30PMBusiness WireSavient Pharmaceuticals Announces CFO Management ChangeNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/03/20056:30PMBusiness WireSavient Updates NASDAQ Hearing and Restatement StatusNASDAQ:SVNTESavient Pharmaceuticals (MM)
      10/03/20056:30AMBusiness WireTwo Abstracts Highlighting Savient Pharmaceuticals' Puricase(R) Accepted for American College of Rheumatology Annual ScientificNASDAQ:SVNTESavient Pharmaceuticals (MM)
      09/21/20057:10AMBusiness WireSavient Pharmaceuticals Files Citizens' Petition with the FDA for Oxandrin(R); Requests FDA to Not Approve Any ANDA Prior to ExpNASDAQ:SVNTESavient Pharmaceuticals (MM)
      09/08/20058:30AMPR Newswire (US)Barr, Organon and Savient Announce Letter of Intent Regarding Mircette(R)NASDAQ:SVNTESavient Pharmaceuticals (MM)
      08/19/20056:30AMBusiness WireSavient Receives Nasdaq Delisting Notice Related to Late Form 10-QNASDAQ:SVNTESavient Pharmaceuticals (MM)
       Showing the most relevant articles for your search:NASDAQ:SVNTE